Lumos Pharma
Presence
Lumos Pharma is a company listed under the stock ticker LUMO (US).
Executives
View the org chart displaying its 21 main executives
Most searched biographies at Lumos Pharma
- Rick Hawkins, Chief Executive Officer, President and Chairman
- Joe McCracken, Director
- Chad Johnson, Board Member
Popular executive movements at Lumos Pharma
- Duke Pitukcheewanont, who was Vice President, Global Clinical Development and Medical Affairs, is promoted to Chief Medical Officer (posted on January 5 2024).
Create your alert
to follow the executive moves at Lumos Pharma.
Pharmaceuticals
Lumos Pharma has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Lumos Pharma
- Lumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in November | Lumos Pharma
- Press Releases | Lumos Pharma
- Lumos Pharma Announces Topline Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials of LUM-201 in PGHD Met All Primary and Secondary Endpoints | Lumos Pharma
- Lumos Pharma Reports Third Quarter 2023 Financial Results and Clinical Development Updates | Lumos Pharma
- Lumos Pharma Announces New Data and Analysis of 15 Subjects from OraGrowtH212 Trial Presented at the 2023 ESPE Annual Meeting | Lumos Pharma
- Lumos Pharma Announced Abstract Accepted for Oral Presentation at the European Society for Paediatric Endocrinology Annual Meeting | Lumos Pharma
- Lumos Pharma Announces Participation in Investor Conferences in September | Lumos Pharma
- Independent Panel of Renowned Pediatric Endocrinologists to Discuss Pediatric Growth Hormone Deficiency and the Therapeutic Landscape | Lumos Pharma
- Lumos Pharma to Report Second Quarter 2022 Financial Results and Host Conference Call on August 9, 2022 | Lumos Pharma
- CEO Update: Interview with Lumos Pharma’s Chief Medical Officer, David B. Karpf, M.D. | Lumos Pharma
- View more press releases Close
Social media about Lumos Pharma
- Lumos Pharma on Wikipedia, Google News & Yahoo Finance
- Lumos Pharma on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Rick Hawkins 
Call Lumos Pharma at +1 512...
